Plain-English translation of NCT05724173 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing the BrainGate2 Neural Interface System, a small sensor implanted in the brain that may help people with paralysis—especially those who have lost the ability to speak—regain communication and control. The device works by reading signals directly from the brain's speech-control areas, then translating those signals into words on a computer screen. Researchers hope this technology could one day restore communication for people with conditions like ALS that affect speech and movement.
Many people with severe paralysis lose their ability to speak but retain their ability to think and understand. This trial exists to develop a treatment that could let these patients communicate again by 'reading' their brain signals, even when their bodies can no longer move or speak.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo brain surgery to place the small BrainGate2 sensor in the speech-control area of your brain. After implantation, you would work with the research team during regular visits to learn how to use the device—essentially teaching the computer to understand your brain signals so it can translate them into spoken words or text. The study lasts at least 15 months, during which you'll work closely with the research team to develop and refine how the implant works for you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States